Thu, Dec 25, 2014
A A A
Welcome Guest
Free Trial RSS
Get FREE trial access to our award winning publications
Alternative Market Briefing

Risk of price manipulation in metal trading may lessen - Part three

Tuesday, May 06, 2014

amb
Jacques Bally
Benedicte Gravrand, Opalesque Geneva:

Jacques Bally, founder of Bally Capital Advisors SA, a Swiss-based investment advisory management company that organized the March Swiss Mining Institute conference in Geneva, talks to Opalesque about US investors in Switzerland, China’s metals imports, price manipulation in metals and a possible golden cross.

Part One is here and Part Two is here.

Jacques Bally: The regulatory environment is very tough in Switzerland and we need to search for new markets complying with the new rules.

Opalesque: : What about US investors?

Jacques Bally: The whole story with the US clients has had a big impact in Switzerland. Of course, in the past 20 years, a lot of Swiss banks and Swiss portfolio managers had US customers that were perhaps not totally well structured from a legal and fiscal point of view. Today the only customers that we have in Switzerland are fiscally 100%.

But because some of the banks are still going through this period of penalties with the US government and so on, only a few banks are today......................

To view our full article Click here

Today's Exclusives Today's Other Voices More Exclusives
Previous Opalesque Exclusives                                  
More Other Voices
Previous Other Voices                                               
Access Alternative Market Briefing


  • Top Forwarded
  • Top Tracked
  • Top Searched
  1. Hong Kong-Shanghai stock link fails to live up to expectation so far[more]

    Komfie Manalo, Opalesque Asia: In a report, Reuters said that demand has been subdued with the bulk of activities coming from short-term speculative investors. Las

  2. Investing - Hedge funds get boost from healthcare in 2014, Paulson & Co takes stake in Salix on heels of inventory issues[more]

    Hedge funds get boost from healthcare in 2014 From Valuewalk.com: The healthcare sector started the year on a turbulent note, as stocks of many major biotechnology companies were battered. However, most of the players in this sector have bounced back. The BarclayHedge Healthcare & Biotec

  3. North America - Why Steve Cohen, Connecticut hedge fund billionaire, gives so much in New York[more]

    From Insidephilantrophy.com: Billionaire Steve Cohen was born in Great Neck, New York before attending Wharton, working on Wall Street and then founding SAC Capital Advisors in Connecticut. Though his company (Point72) and foundation are based in Connecticut, Cohen and Alexandra are deeply connected

  4. Investing - Soros buys a highly speculative biotech in the third quarter[more]

    From Fool.com: …The Soros Fund bought 25,000 shares of the struggling small-cap biopharma Aegerion Pharmaceuticals in the third quarter. For those of you who haven't heard of this name, suffice to say that this was a surprising buy in light of the company's recent problems and poor outlook going for

  5. CFTC Revokes Registrations of Illinois Resident Aleks A. Kins and Chicago-based AlphaMetrix, LLC[more]

    Matthias Knab, Opalesque: The U.S. Commodity Futures Trading Commission (CFTC) today announced that it has revoked the registration of Aleks A. Kins of Chicago, Illinois, as an Associated Person and the registrations of AlphaMetrix, LLC (AlphaMetrix), a Delaware limited liability company with its